Figure 5
From: Prognostic significance of FLT3-ITD length in AML patients treated with intensive regimens
Flow diagram showing all AML patients with FLT3-ITD mutations in the study period between 2003 and 2019 on the basis of genetic data and treatment administered. NGS, next-generation sequencing.
